{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:59:10Z","timestamp":1791489550402,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaut.2024.103277","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T19:16:30Z","timestamp":1720293390000},"page":"103277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-\u03b2 and SMAD3 signaling pathway activation"],"prefix":"10.1016","volume":"148","author":[{"given":"Jinghua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-7788","authenticated-orcid":false,"given":"Lindi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103277_bib1","first-page":"2","article-title":"Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society","volume":"75","author":"Group","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.jaut.2024.103277_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11926-019-0848-3","article-title":"Takayasu arteritis: recent developments","volume":"21","author":"Zaldivar Villon","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2024.103277_bib3","first-page":"1","article-title":"Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis","volume":"36","author":"Kong","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103277_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajpath.2019.10.021","article-title":"Recent developments in vascular adventitial pathobiology: the dynamic adventitia as a complex regulator of vascular disease","volume":"190","author":"Tinajero","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2024.103277_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.01.010","article-title":"Autophagy promotes aortic adventitial fibrosis via the IL-6\/Jak1 signaling pathway in Takayasu's arteritis","volume":"99","author":"Chen","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103277_bib6","first-page":"6","article-title":"CYR61\/TGF-beta axis promotes adventitial fibrosis of Takayasu's arteritis in the IL-17 mediated inflammatory microenvironment","volume":"38","author":"Ma","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103277_bib7","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1038\/nature10152","article-title":"Latent TGF-beta structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103277_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.39035","article-title":"Identification of susceptibility loci in IL6, RPS9\/LILRB3, and an intergenic locus on chromosome 21q22 in Takayasu arteritis in a genome-wide association study","volume":"67","author":"Renauer","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103277_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/endrev\/bnaa033","article-title":"Mouse models of human proprotein convertase insufficiency","volume":"42","author":"Shakya","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2024.103277_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.90.14.6691","article-title":"cDNA structure of the mouse and rat subtilisin\/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells","volume":"90","author":"Lusson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2024.103277_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.26.1.354-361.2006","article-title":"Deletion of the gene encoding proprotein convertase 5\/6 causes early embryonic lethality in the mouse","volume":"26","author":"Essalmani","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2024.103277_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.devcel.2017.10.027","article-title":"Tumor-suppressor inactivation of GDF11 occurs by precursor sequestration in triple-negative breast cancer","volume":"43","author":"Bajikar","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jaut.2024.103277_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/MCB.00249-18","article-title":"Growth differentiation factor 15 maturation requires proteolytic cleavage by PCSK3, -5, and -6","volume":"38","author":"Li","year":"2018","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2024.103277_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2017.11.002","article-title":"Osteopontin as a novel substrate for the proprotein convertase 5\/6 (PCSK5) in bone","volume":"107","author":"Hoac","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.jaut.2024.103277_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00109-011-0776-9","article-title":"Inactivation of endothelial proprotein convertase 5\/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy","volume":"89","author":"Marchesi","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.jaut.2024.103277_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103277_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijcard.2010.10.002","article-title":"Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging","volume":"155","author":"Jiang","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2024.103277_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2022.12.004","article-title":"A novel molecular mechanism of vascular fibrosis in Takayasu arteritis: macrophage-derived GPNMB promoting adventitial fibroblast extracellular matrix production in the aorta","volume":"255","author":"Dai","year":"2023","journal-title":"Transl. Res."},{"issue":"3 Suppl 97","key":"10.1016\/j.jaut.2024.103277_bib19","article-title":"The critical role of IL-6 in the pathogenesis of Takayasu arteritis","volume":"34","author":"Kong","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103277_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biocel.2008.01.030","article-title":"The activation and physiological functions of the proprotein convertases","volume":"40","author":"Seidah","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jaut.2024.103277_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1074\/jbc.R113.481549","article-title":"The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions","volume":"288","author":"Seidah","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2024.103277_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jaut.2024.103277_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1110\/ps.062416606","article-title":"Statistical potential for assessment and prediction of protein structures","volume":"15","author":"Shen","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.jaut.2024.103277_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2024.103277_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103277_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152018","article-title":"Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: a prospective study","volume":"55","author":"Wang","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103277_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2024.103277_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.39037","article-title":"Th1 and Th17 cytokines drive inflammation in Takayasu arteritis","volume":"67","author":"Saadoun","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103277_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63970-3","article-title":"Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme","volume":"158","author":"Dubois","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2024.103277_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2024.103277_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrd3699","article-title":"The biology and therapeutic targeting of the proprotein convertases","volume":"11","author":"Seidah","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2024.103277_bib32","article-title":"The potential future role of extensive lipid lowering in ACS patients with the use of PCSK9 inhibitors: early bird catches the worm","author":"Dimitriadis","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jaut.2024.103277_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.celrep.2020.108254","article-title":"Furin inhibitors block SARS-CoV-2 spike protein cleavage to suppress virus production and cytopathic effects","volume":"33","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2024.103277_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0162-3109(00)00191-0","article-title":"Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases","volume":"47","author":"Herrmann","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaut.2024.103277_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/Y09-094","article-title":"Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+CD25+ regulatory T cells","volume":"88","author":"Wang","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jaut.2024.103277_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20930114","article-title":"Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study","volume":"12","author":"Ying","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jaut.2024.103277_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320975233","article-title":"Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis","volume":"11","author":"Wu","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"Suppl 124","key":"10.1016\/j.jaut.2024.103277_bib38","first-page":"2","article-title":"The potential role of leflunomide in inhibiting vascular fibrosis by down-regulating type-II macrophages in Takayasu's arteritis","volume":"38","author":"Cui","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103277_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2017.12.066","article-title":"Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide","volume":"266","author":"Kong","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2024.103277_bib40","doi-asserted-by":"crossref","DOI":"10.2147\/JIR.S369963","article-title":"Biomarker changes and molecular signatures associated with Takayasu arteritis following treatment with glucocorticoids and tofacitinib","volume":"15","author":"Dai","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jaut.2024.103277_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keab788","article-title":"FABP3 overexpression promotes vascular fibrosis in Takayasu's arteritis by enhancing fatty acid oxidation in aorta adventitial fibroblasts","volume":"61","author":"Wu","year":"2022","journal-title":"Rheumatology (Oxford)."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:45:35Z","timestamp":1725803135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":41,"alternative-id":["S0896841124001112"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103277","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-\u03b2 and SMAD3 signaling pathway activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103277"}}